David Wood, Ireland
National Institute for Prevention & Cardiovascular Health, National University of Ireland Croí Heart and Stroke Centre
Moderator of 1 Session
Session Time
14:00 - 15:30
Session Evaluation
Please enter to our survey here
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1576,"presentation":"Introduction","session":"Targeting lower LDL-C: When and how?","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"1576-Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/B42548F0.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1576-2.vtt"}]},{"name":"Are the new EAS\/ESC lipids goals reachable in clinical practice?","mode":"playlist","public":true,"info":{"id":1508,"presentation":"Are the new EAS\/ESC lipids goals reachable in clinical practice?","session":"Targeting lower LDL-C: When and how?","presenter":"Fran\u00e7ois Mach, Switzerland","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"Mach - EAS20 - 1508 - Are the new EAS\/ESC lipids goals reachable in clinical practice?","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1508.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/1508.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/C6C6FA52.jpg","data":[],"tracks":[]}]},{"name":"Risk stratification in very high risk patients is it of value?","mode":"playlist","public":true,"info":{"id":1509,"presentation":"Risk stratification in very high risk patients is it of value?","session":"Targeting lower LDL-C: When and how?","presenter":"Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/1332.jpg"},"playlist":[{"name":"Kausik Ray - EAS20 - 1509 - Risk stratification in very high risk patients is it of value","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/Kausik Ray - EAS20 - 1509 - Risk stratification in very high risk patients is it of value.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/Kausik Ray - EAS20 - 1509 - Risk stratification in very high risk patients is it of value.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/8A00E2F9.jpg","data":[],"tracks":[]}]},{"name":"An update on the results of ODYSSEY outcomes","mode":"playlist","public":true,"info":{"id":1510,"presentation":"An update on the results of ODYSSEY outcomes","session":"Targeting lower LDL-C: When and how?","presenter":"Philippe G. Steg, France","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5389.jpg"},"playlist":[{"name":"An update on the results of ODYSSEY outcomes","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1510.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/1510.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/3DEA6236.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/1510.vtt"}]},{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1577,"presentation":"Panel Discussion with Live Q&A","session":"Targeting lower LDL-C: When and how?","presenter":"David Wood, Ireland, Lale Tokg\u00f6zo\u011flu, Turkey, Fran\u00e7ois Mach, Switzerland, Philippe G. Steg, France, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Targeting lower LDL-C When and how","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/Targeting lower LDL-C When and how.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/Targeting lower LDL-C When and how.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/CAE4AD81.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"8E32Xi02Q"}
[session]
[presentation]
[presenter]
Presenter of 1 Presentation
Panel Discussion with Live Q&A
Session Time
14:00 - 15:30
Lecture Time
15:15 - 15:30
[{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1577,"presentation":"Panel Discussion with Live Q&A","session":"Targeting lower LDL-C: When and how?","presenter":"David Wood, Ireland, Lale Tokg\u00f6zo\u011flu, Turkey, Fran\u00e7ois Mach, Switzerland, Philippe G. Steg, France, Kausik K. Ray, United Kingdom","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Targeting lower LDL-C When and how","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/Targeting lower LDL-C When and how.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/106\/Targeting lower LDL-C When and how.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/106\/CAE4AD81.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0tc"}
[session]
[presentation]
[presenter]
Hide